Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardio...

por Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck-Nielsen, H., Viberti, G.
Publicado 2010